Meeting Abstract
Gynecologic Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Laura Doherty, FNP-BC, AOCNP®
Women & Infants Hospital of Rhode Island/Brown University
J Adv Pract Oncol 2021;12(6):621-628 |
https://doi.org/10.6004/jadpro.2021.12.6.9 |
© 2021 Harborside™
ABSTRACT
Laura Doherty, FNP-BC, AOCNP®, of Women & Infants Hospital of Rhode Island/Brown University, interprets data on adjuvant chemotherapy for locally advanced cervical cancer, bevacizumab for advanced ovarian cancer, a new treatment option for platinum-resistant ovarian cancer patients, and side effects that long-term ovarian cancer survivors experience. Reporting by The ASCO Post.
For access to the full length article, please
sign in.
